LATAM Cargo's Europe-Brazil pharma volume jumps 150% on GLP-1 demand

I have been booking Europe-Brazil air freight for the better part of a decade, and when a carrier publishes a 27% year-on-year volume lift on a mature lane, my instinct is to look at what sits underneath the headline rather than celebrate the growth. LATAM Cargo moved close to 32,000 tonnes between Europe and Brazil in the first seven months of this year. That is a big number on its own, but the composition is the real story for anyone who has to get goods onto those planes in the fourth quarter.

Pharmaceutical freight is up 150% against the first seven months of 2025. Let that sit for a second. A tripling-and-more of pharma volume on a corridor that has spent years moving industrial kit, mining machinery and textiles is not a seasonal wobble. It signals a structural shift in what flies between the two continents. And GLP-1 diabetes drugs, the injectables that have been in the news everywhere, now make up roughly 15% of the Europe-to-Brazil volume on their own. Fifteen percent of the entire corridor, from a category that was a rounding error a few years ago.

That 15% is the part I would flag hardest to any importer or exporter on this trade, because GLP-1 products are temperature-controlled, high-value, and completely unforgiving of a broken cold chain. The demand is concentrated on Frankfurt-Viracopos and Brussels-Viracopos, the two lanes where LATAM is clearly concentrating its cold capacity. When a single category takes 15% of lane space and it needs 2 to 8 degrees Celsius end to end, you feel it on the booking board immediately: the cold-capable bellies fill first, and the general cargo that used to slide in gets pushed to later flights or onto competing carriers.

Here is the trap a lot of general-cargo shippers fall into. They see pharma in the headline and assume it has nothing to do with their machine parts or textile orders. It does. General cargo still holds about 75% of total tonnage, with industrial equipment, mining machinery and textiles leading that bucket, but the aircraft is one asset. If the cold-capable bellies are sold to pharma first, the remaining space for everyone else is tighter than the raw 27% growth figure suggests, and your confirmed-booking lead time stretches even though your own cargo never touches a reefer.

Let me put a number on that, because saying it is busy by itself is not something you can act on. Say you are an industrial-equipment shipper moving around 40 tonnes a month into Sao Paulo through Viracopos. On a calm market you would expect to confirm space within three or four days of tendering the booking. On a corridor growing 27% with a 150% pharma spike eating priority bellies, that confirmation window can slip to seven or ten days, and you may get quoted on a flight a day or two later than the one you wanted. At a notional air rate of 2.50 US dollars per kilo for that commodity, a one-week delay on 40 tonnes is not just a scheduling annoyance. If it trips a factory-line stoppage or a contractual delivery penalty at the Brazil end, the cost of the slip swamps the freight cost.

The instinct when space tightens is to panic and ship early, but that just pulls demand forward and makes the squeeze worse for everyone, including you next month. The move that actually protects you is to change how you tender. From what I have seen on busy lanes, the teams that get burned are the ones who treat air booking like a spot market and call the forwarder the week the goods are ready. On a corridor like this, you want a rolling monthly volume commit with a protected block, not a same-week ask.

A protected block, for anyone who has not negotiated one, is a guaranteed slice of capacity at an agreed rate, reserved against your forecast rather than released to the open market. You pay a small premium for the guarantee, and you usually carry a cancellation or minimum-utilisation clause. The premium is cheap insurance when the alternative is watching your shipment roll to a flight three days late because a pharma consolidation filled the plane. Give your freight forwarder a monthly commit by mid-October and ask for protection through the end of the year.

For the pharma shippers reading this, the immediate lesson is to audit your lane plan before the fourth quarter piles on top of an already-hot market. Frankfurt and Brussels into Viracopos are the hotspots, which means they will be the first to tighten and the first to see rate creep. If your product profile allows, qualify a secondary gateway now, Madrid, Amsterdam, or direct options through other carriers, and do the GDP validation work with your Brazilian receiver before you are forced to. Qualifying a backup cold lane realistically takes three to four weeks of paperwork, trial flights and quality-agreement sign-off. You do not want to be starting that in week two of a capacity crunch.

I would also watch the reverse direction, because almost everyone only looks one way when they see these numbers. Capacity is sold as a round trip, and if the Brazil-outbound legs are not balanced, the carrier will protect the direction that pays. If you are exporting Brazilian goods into Europe on the same corridor, think fruit, coffee, manufactured components, do not assume the southbound belly stays loose. Fold the round-trip conversation into your freight contract so you are not negotiating each leg at the worst possible moment.

Compliance deserves a hard look too. Pharma into Brazil means ANVISA oversight, and cold-chain documentation gets scrutinised far more closely when volumes spike and every handler is rushing. I have watched shipments held at Viracopos because the temperature-logger data was not in the format the receiver's quality team expected, and the delay cost more than the flight itself. Tidy your cold-chain pack-out, pre-clear the documentation template with your Brazilian importer, and agree the excursion-handling protocol before the box leaves Europe, not after someone is standing over a pallet wondering what to do.

For general-cargo shippers the advice is simpler but no less urgent: lengthen your planning horizon and build buffer into the transit you quote your own customers. If your current standard is book five days out, move it to book ten days out for the fourth quarter. The corridor's 27% growth is not going to absorb itself, and the back half of the year is when both pharma and industrial shipments stack up ahead of the holidays and year-end closures.

On cost, when a lane heats up the surcharges come out of the woodwork: peak-season surcharges, security fees, fuel adjustments. None of those are line items you can simply wave away, but you can cap your exposure by fixing a rate with a validity window rather than accepting spot each time. A three-month fixed quote with a modest uplift beats chasing a volatile market month to month, particularly when you are committing volume the carrier wants to keep.

There is a converse risk worth naming: do not over-commit in a panic. A protected block is only as good as your forecast, and if you lock 40 tonnes a month and only ship 25, the cancellation or minimum-utilisation clause bites. Build the commit from a trailing three-month average plus a sensible growth add, and review it monthly with the forwarder. The goal is protection, not a vanity guarantee you pay for and do not use.

Inventory positioning is the quieter lever here. If your Brazil demand is steady, holding a buffer stock at a Viracopos-area warehouse against a four-to-six-week air plan hedges you against both the booking slip and the rate creep, at the cost of carrying inventory. For high-value pharma that is often worth it; for bulky textiles it rarely is. The right call depends on your margin and your Brazil-side storage cost, not on a generic rule.

One more practical point on forwarder selection. On a tightening lane, the forwarder with the best published rate is not always the one who gets you space. Ask directly about their blocked capacity with the carrier, their historical uplift performance on Frankfurt-Viracopos and Brussels-Viracopos, and what happens to your shipment when the plane is oversold. The answer tells you more than any rate sheet.

I would also suggest you track the right metric going forward, not just whether the shipment flew. Watch your confirmed-booking lead time week to week, your uplift rate against booked, and the gap between quoted and actual departure. On a 27%-growth lane those three numbers drift fast, and they are your early warning that protection is slipping. A simple spreadsheet your coordinator updates every Monday beats a quarterly surprise.

And if you are a smaller shipper who cannot command a protected block on your own, this is exactly the moment to pool with peers or lean on a forwarder's consolidated product. The consolidation that is filling these planes is also what can get you on them. Ask about shared-block or deferred-product options rather than assuming you are priced out of the lane.

Pulling this together from the desk of someone who has been caught on both empty bellies and oversold ones: the Europe-Brazil corridor is in a growth phase driven by pharma, but the pain spreads to everyone because the aircraft is a single shared asset. Lock capacity early on a rolling commit, qualify a backup cold lane, tidy your Brazil-side compliance, and stop treating air booking as a last-minute phone call. The numbers say this tightens before it loosens, so plan for the tighten.

Step back and look at the 75% that is not pharma, because that bucket behaves differently by commodity. Mining machinery moving into Brazil tends to be project-linked, with long lead times and little tolerance for a slipped flight, while textiles run on seasonal cycles where a late shipment misses a selling window entirely. The 27% overall growth is an average; your own exposure depends on which slice of that 75% you sit in, and you should size your buffer against your specific commodity's penalty for being late, not against a headline number.

Insurance is the piece too many shippers forget until a claim goes sideways. On a heated lane where delays are more likely, your cargo policy and your cold-chain excursion clause deserve a look before the fourth quarter. Under a CIF or CIP term the seller carries risk to the port of arrival, but the cost of a temperature excursion on pharma still lands somewhere, and under EXW or FOB the buyer owns the risk from the moment goods leave the warehouse. Match your Incoterm to who can actually absorb a delay without the shipment falling into a no-man's-land of finger-pointing.

Viracopos itself is only the first leg for most cargo. A lot of what lands there feeds onward by road into the Brazilian interior, and a delayed international flight compounds with a domestic truck that was scheduled to a fixed window. If your final delivery is Campinas-plus-a-day rather than the airport gate, build the domestic leg into your buffer too. The international delay is visible; the domestic knock-on is what actually misses the customer.

On forecasting the commit I mentioned, the mistake is to hand your forwarder a hopeful number. The protected block only works if the volume is real, so build it from a trailing three-month actual plus a growth add you can defend, and share the underlying order book where you can. A forwarder who sees your real pipeline will protect you more reliably than one who is guessing, and the relationship is the whole game on a tightening lane.

And do not forget the other carriers on this corridor. LATAM is the headline here, but when one airline's bellies tighten, the others, be they European or Middle Eastern carriers with a Brazil foot, become the relief valve. Keep a second carrier qualified even if you ship mostly with one, because the day you need capacity the carrier you never used will ask more questions than the one you know. A qualified fallback is a few phone calls now, not a fire drill later.

One more operational habit: agree the cut-off and the confirmation discipline in writing with your forwarder before the peak. On a busy lane the difference between a shipment that flies and one that rolls is often whether the booking was confirmed against a protected block or chased as a spot ask at the last hour. Put the service level in the agreement, with a consequence if they miss, and you turn a vague promise into something you can manage.

There is a timing dimension to the fourth quarter that deserves its own sentence. The corridor's 27% growth lands on top of normal year-end volume, and the weeks straddling the holiday factory closures in both Europe and Brazil are where the squeeze bites hardest. If your goods must arrive before a specific December date, tender against the protected block in early November, not late November, because the late-November bookings are the ones that compete with everyone else's panic.

Look at your incoterms again in this context. A shipment that rolls because the lane is full is a delay whoever owns the freight, but the cost of that delay flows according to the contract. If you are the buyer on FOB and the flight slips, you still owe the seller and you still owe your own production line; if you are the seller on CIF, the roll is your problem to solve. Name the delay ownership in the contract before the peak, not after a missed delivery.

And keep a simple scorecard. On a lane this volatile, the teams that cope are the ones measuring week to week: confirmed lead time, uplift rate, actual versus quoted departure, and the share of shipments that needed a rebook. A one-page Monday update beats a quarterly post-mortem, and it tells you early when the protected block is no longer enough and you need to widen the commit or add the second carrier.

One more thing on the pharma side specifically. The 15% GLP-1 share is growing, not static, and as more patients come onto these drugs the cold demand will keep climbing through next year. If you are building a cold lane plan, size it for the trend, not just today's number, because the capacity you lock this quarter is the capacity you will wish you had when the next growth print lands.

I would also flag the documentation discipline for general cargo that often gets overlooked. When a lane tightens, handlers triage, and incomplete or sloppy paperwork is the quiet reason good bookings still miss flights. A clean commercial invoice, packing list and any certificate the Brazilian side expects, submitted with the booking rather than chased later, is a cheap way to stay at the front of the queue. The plane does not wait for a missing document.

Let me close with the simplest advice that most people ignore. The corridor is growing, pharma is pulling cold capacity, and the fourth quarter will be tight, but none of that requires you to panic. It requires you to plan a little earlier than you did last year and to put your commitments in writing. The teams that sail through busy lanes are not the ones with the biggest budgets, they are the ones who treated the booking as a contract months ahead instead of a phone call the week before. Do that, and the 27% growth becomes someone else's problem, not yours.

One closing thought for the finance team, because they often see only the freight invoice. A protected block costs a small premium and a commit, but on a lane where a one-week slip can trigger a penalty many times the freight, that premium is the cheapest insurance on the balance sheet. Put the maths in front of them with the 40-tonne example above, and the question stops being whether to lock capacity and becomes how much to lock.

• Lock a rolling monthly capacity block with your forwarder for Europe-Brazil by 17 October, covering general and any cold cargo, at a fixed rate valid through 31 December.
• Qualify at least one secondary cold-chain gateway, Madrid or Amsterdam into Viracopos, with GDP validation completed by 14 November; budget three to four weeks for paperwork and trial flights.
• Extend your fourth-quarter booking lead time from five to ten days for general cargo to absorb the 27% corridor growth and the holiday pile-up.
• Pre-align ANVISA cold-chain documentation and the excursion-handling protocol with your Brazilian receiver before any pharma box leaves Europe.
• Build the round-trip southbound Brazil-Europe capacity into your freight contract so you are not negotiating each leg at peak.
• Cap surcharge exposure with a three-month fixed-rate quote instead of accepting monthly spot on this heated lane.